(EN) Disclosed herein are high titer, monospecific, polyclonal antibodies to Shiga- like toxins. Also disclosed are methods for producing such antibodies; compositions containing them, and methods for the diagnosis; prevention, and treatment of diseases caused by. Shiga-like toxins. These include hemiorrhagic colitis and hemolytic uremic syndrome in humans, edema disease in swine, and calf diarrhea in cattle:
|